Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 451

1.

Wait-and-See Policy for a Small Pancreatic Schwannoma Diagnosed With Endoscopic Ultrasound With Fine-Needle Aspiration.

Bruno M, Maletta F, Gaia S, Venezia L, Cortegoso Valdivia P, Saracco GM, De Angelis CG.

ACG Case Rep J. 2019 Jul 24;6(7):e00139. doi: 10.14309/crj.0000000000000139. eCollection 2019 Jul.

2.

Evidence of Cascaded Third-Harmonic Generation in Noncentrosymmetric Gold Nanoantennas.

Celebrano M, Locatelli A, Ghirardini L, Pellegrini G, Biagioni P, Zilli A, Wu X, Grossmann S, Carletti L, De Angelis C, Duò L, Hecht B, Finazzi M.

Nano Lett. 2019 Oct 9;19(10):7013-7020. doi: 10.1021/acs.nanolett.9b02427. Epub 2019 Sep 5.

PMID:
31461291
3.

Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer.

Sethunath V, Hu H, De Angelis C, Veeraraghavan J, Qin L, Wang N, Simon LM, Wang T, Fu X, Nardone A, Pereira R, Nanda S, Griffith OL, Tsimelzon A, Shaw C, Chamness GC, Reis-Filho JS, Weigelt B, Heiser LM, Hilsenbeck SG, Huang S, Rimawi MF, Gray JW, Osborne CK, Schiff R.

Mol Cancer Res. 2019 Aug 16. doi: 10.1158/1541-7786.MCR-19-0756. [Epub ahead of print]

PMID:
31420371
4.

Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit.

Provvisiero DP, Negri M, de Angelis C, Di Gennaro G, Patalano R, Simeoli C, Papa F, Ferrigno R, Auriemma RS, De Martino MC, Colao A, Pivonello R, Pivonello C.

Sci Rep. 2019 Aug 12;9(1):11695. doi: 10.1038/s41598-019-48081-9.

5.

Silicon Metasurfaces for Third Harmonic Geometric Phase Manipulation and Multiplexed Holography.

Reineke B, Sain B, Zhao R, Carletti L, Liu B, Huang L, De Angelis C, Zentgraf T.

Nano Lett. 2019 Sep 11;19(9):6585-6591. doi: 10.1021/acs.nanolett.9b02844. Epub 2019 Aug 15.

6.

Metabolic Disorders and Male Hypogonadotropic Hypogonadism.

Pivonello R, Menafra D, Riccio E, Garifalos F, Mazzella M, de Angelis C, Colao A.

Front Endocrinol (Lausanne). 2019 Jul 25;10:345. doi: 10.3389/fendo.2019.00345. eCollection 2019. Review.

7.

Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.

Cantini L, Pistelli M, Merloni F, Fontana A, Bertolini I, De Angelis C, Bastianelli L, Della Mora A, Santinelli A, Savini A, Maccaroni E, Diodati L, Falcone A, Berardi R.

Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(19)30081-3. doi: 10.1016/j.clbc.2019.06.008. [Epub ahead of print]

PMID:
31378534
8.

Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients.

Del Re M, Bertolini I, Crucitta S, Fontanelli L, Rofi E, De Angelis C, Diodati L, Cavallero D, Gianfilippo G, Salvadori B, Fogli S, Falcone A, Scatena C, Naccarato AG, Roncella M, Ghilli M, Morganti R, Fontana A, Danesi R.

Breast Cancer Res Treat. 2019 Nov;178(1):57-62. doi: 10.1007/s10549-019-05365-y. Epub 2019 Jul 26.

PMID:
31346846
9.

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri EM, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P.

Int J Cancer. 2019 Jul 22. doi: 10.1002/ijc.32583. [Epub ahead of print]

PMID:
31330065
10.

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.

La Ferla M, Lessi F, Aretini P, Pellegrini D, Franceschi S, Tantillo E, Menicagli M, Marchetti I, Scopelliti C, Civita P, De Angelis C, Diodati L, Bertolini I, Roncella M, McDonnell LA, Hochman J, Del Re M, Scatena C, Naccarato AG, Fontana A, Mazzanti CM.

Front Oncol. 2019 Jun 26;9:547. doi: 10.3389/fonc.2019.00547. eCollection 2019. Erratum in: Front Oncol. 2019 Jul 18;9:709.

11.

Framing of the opioid problem in cancer pain management in Canada.

Asthana R, Goodall S, Lau J, Zimmermann C, Diaz PL, Wan AB, Chow E, De Angelis C.

Curr Oncol. 2019 Jun;26(3):e410-e413. doi: 10.3747/co.26.4517. Epub 2019 Jun 1.

12.

Output factor measurement in high dose-per-pulse IORT electron beams.

Pimpinella M, Andreoli S, De Angelis C, Della Monaca S, D'Arienzo M, Menegotti L.

Phys Med. 2019 May;61:94-102. doi: 10.1016/j.ejmp.2019.04.021. Epub 2019 May 3.

PMID:
31151586
13.

THE TOP-IMPLART PROTON LINEAR ACCELERATOR: INTERIM CHARACTERISTICS OF THE 35 MEV BEAM.

De Angelis C, Ampollini A, Bazzano G, Della Monaca S, Ghio F, Giuliani F, Lucentini M, Montereali RM, Nenzi P, Notaro C, Placido C, Piccinini M, Ronsivalle C, Santavenere F, Soriani A, Spurio A, Strigari L, Surrenti V, Trinca E, Vadrucci M, Cisbani E, Picardi L.

Radiat Prot Dosimetry. 2019 May 29. pii: ncz142. doi: 10.1093/rpd/ncz142. [Epub ahead of print]

PMID:
31141142
14.

Laser thermal ablation to treat a recurrent soft-tissue sarcoma of the leg: a case report.

De Angelis C, Vigna PD, Varano GM, Mauri G.

Ecancermedicalscience. 2019 Mar 5;13:908. doi: 10.3332/ecancer.2019.908. eCollection 2019.

15.

Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients-a prospective clinical study.

Asthana R, Zhang L, Wan BA, Gallo-Hershberg D, Giotis A, Pasetka M, van Draanen J, Goodall S, Diaz PL, Drost L, Chow E, De Angelis C.

Support Care Cancer. 2019 May 17. doi: 10.1007/s00520-019-04845-7. [Epub ahead of print]

PMID:
31098795
16.

HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade.

Prat A, Pascual T, De Angelis C, Gutierrez C, Llombart-Cussac A, Wang T, Cortés J, Rexer B, Paré L, Forero A, Wolff AC, Morales S, Adamo B, Brasó-Maristany F, Vidal M, Veeraraghavan J, Krop I, Galván P, Pavlick AC, Bermejo B, Izquierdo M, Rodrik-Outmezguine V, Reis-Filho JS, Hilsenbeck SG, Oliveira M, Dieci MV, Griguolo G, Fasani R, Nuciforo P, Parker JS, Conte P, Schiff R, Guarneri V, Osborne CK, Rimawi MF.

J Natl Cancer Inst. 2019 Apr 30. pii: djz042. doi: 10.1093/jnci/djz042. [Epub ahead of print]

PMID:
31037288
17.

The Relationships Between Vitamin K and Cognition: A Review of Current Evidence.

Alisi L, Cao R, De Angelis C, Cafolla A, Caramia F, Cartocci G, Librando A, Fiorelli M.

Front Neurol. 2019 Mar 19;10:239. doi: 10.3389/fneur.2019.00239. eCollection 2019. Review.

18.

Emergent Laparoscopic Removal of a Perforating Intrauterine Device During Pregnancy Under Regional Anesthesia.

Giampaolino P, Della Corte L, Di Spiezio Sardo A, Zizolfi B, Manzi A, De Angelis C, Bifulco G, Carugno J.

J Minim Invasive Gynecol. 2019 Sep - Oct;26(6):1013-1014. doi: 10.1016/j.jmig.2019.03.012. Epub 2019 Mar 23.

PMID:
30914327
19.

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.

Veeraraghavan J, De Angelis C, Mao R, Wang T, Herrera S, Pavlick AC, Contreras A, Nuciforo P, Mayer IA, Forero A, Nanda R, Goetz MP, Chang JC, Wolff AC, Krop IE, Fuqua SAW, Prat A, Hilsenbeck SG, Weigelt B, Reis-Filho JS, Gutierrez C, Osborne CK, Rimawi MF, Schiff R.

Ann Oncol. 2019 Mar 23. pii: mdz076. doi: 10.1093/annonc/mdz076. [Epub ahead of print]

PMID:
30903140
20.

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis.

Ramirez AB, Bhat R, Sahay D, De Angelis C, Thangavel H, Hedayatpour S, Dobrolecki LE, Nardone A, Giuliano M, Nagi C, Rimawi M, Osborne CK, Lewis MT, Stilwell JL, Kaldjian EP, Schiff R, Trivedi MV.

BMC Cancer. 2019 Mar 12;19(1):220. doi: 10.1186/s12885-019-5382-1.

21.

Low endometrial beta-catenin and cadherins expression patterns are predictive for primary infertility and recurrent pregnancy loss.

Bellati F, Costanzi F, De Marco MP, Cippitelli C, Stoppacciaro A, De Angelis C, Ruscito I, Rago R, Caserta D.

Gynecol Endocrinol. 2019 Aug;35(8):727-731. doi: 10.1080/09513590.2019.1579790. Epub 2019 Feb 26.

PMID:
30806528
22.

DETECTION OF IONIZING RADIATION TREATMENT IN GLASS USED FOR HEALTHCARE PRODUCTS.

Bortolin E, De Angelis C, Quattrini MC, Barlascini O, Fattibene P.

Radiat Prot Dosimetry. 2019 Feb 26. pii: ncz014. doi: 10.1093/rpd/ncz014. [Epub ahead of print]

PMID:
30806468
23.

Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients.

Ribaldone DG, Fagoonee S, Astegiano M, Durazzo M, Morgando A, Sprujevnik T, Giordanino C, Baronio M, De Angelis C, Saracco GM, Pellicano R.

J Clin Med. 2019 Feb 6;8(2). pii: E199. doi: 10.3390/jcm8020199.

24.

Neratinib in HER2-Positive Breast Cancer Patients.

Paranjpe R, Basatneh D, Tao G, De Angelis C, Noormohammed S, Ekinci E, Abughosh S, Ghose R, Trivedi MV.

Ann Pharmacother. 2019 Jun;53(6):612-620. doi: 10.1177/1060028018824088. Epub 2019 Jan 4.

PMID:
30607980
25.

Air pollution and female fertility: a systematic review of literature.

Conforti A, Mascia M, Cioffi G, De Angelis C, Coppola G, De Rosa P, Pivonello R, Alviggi C, De Placido G.

Reprod Biol Endocrinol. 2018 Dec 30;16(1):117. doi: 10.1186/s12958-018-0433-z.

26.

The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance.

Nardone A, Weir H, Delpuech O, Brown H, De Angelis C, Cataldo ML, Fu X, Shea MJ, Mitchell T, Veeraraghavan J, Nagi C, Pilling M, Rimawi MF, Trivedi M, Hilsenbeck SG, Chamness GC, Jeselsohn R, Osborne CK, Schiff R.

Br J Cancer. 2019 Feb;120(3):331-339. doi: 10.1038/s41416-018-0354-9. Epub 2018 Dec 17.

PMID:
30555156
27.

Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients.

Rascon K, Flajc G, De Angelis C, Liu X, Trivedi MV, Ekinci E.

Ann Pharmacother. 2019 May;53(5):501-509. doi: 10.1177/1060028018817904. Epub 2018 Dec 7.

PMID:
30522347
28.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.

Pizzuti L, Giordano A, Michelotti A, Mazzotta M, Natoli C, Gamucci T, De Angelis C, Landucci E, Diodati L, Iezzi L, Mentuccia L, Fabbri A, Barba M, Sanguineti G, Marchetti P, Tomao S, Mariani L, Paris I, Lorusso V, Vallarelli S, Cassano A, Aroldi F, Orlandi A, Moscetti L, Sergi D, Sarobba MG, Tonini G, Santini D, Sini V, Veltri E, Vaccaro A, Ferrari L, De Tursi M, Tinari N, Grassadonia A, Greco F, Botticelli A, La Verde N, Zamagni C, Rubino D, Cortesi E, Magri V, Pomati G, Scagnoli S, Capomolla E, Kayal R, Scinto AF, Corsi D, Cazzaniga M, Laudadio L, Forciniti S, Mancini M, Carbognin L, Seminara P, Barni S, Samaritani R, Roselli M, Portarena I, Russo A, Ficorella C, Cannita K, Carpano S, Pistelli M, Berardi R, De Maria R, Sperduti I, Ciliberto G, Vici P.

J Cell Physiol. 2019 Jun;234(6):7708-7717. doi: 10.1002/jcp.27832. Epub 2018 Dec 10.

PMID:
30536609
29.

Effectiveness of Hysteroscopic Techniques for Endometrial Polyp Removal: The Italian Multicenter Trial.

Luerti M, Vitagliano A, Di Spiezio Sardo A, Angioni S, Garuti G, De Angelis C; Italian School of Minimally Invasive Gynecological Surgery Hysteroscopists Group.

J Minim Invasive Gynecol. 2019 Sep - Oct;26(6):1169-1176. doi: 10.1016/j.jmig.2018.12.002. Epub 2018 Dec 7.

PMID:
30528831
30.

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer.

Guarducci C, Bonechi M, Benelli M, Biagioni C, Boccalini G, Romagnoli D, Verardo R, Schiff R, Osborne CK, De Angelis C, Di Leo A, Malorni L, Migliaccio I.

NPJ Breast Cancer. 2018 Nov 28;4:38. doi: 10.1038/s41523-018-0092-4. eCollection 2018.

31.

Quantitative imaging of membrane micropolarity in living cells and tissues by spectral phasors analysis.

Di Giacinto F, De Angelis C, De Spirito M, Maulucci G.

MethodsX. 2018 Oct 29;5:1399-1412. doi: 10.1016/j.mex.2018.10.010. eCollection 2018.

32.

Shaping the Nonlinear Emission Pattern of a Dielectric Nanoantenna by Integrated Holographic Gratings.

Ghirardini L, Marino G, Gili VF, Favero I, Rocco D, Carletti L, Locatelli A, De Angelis C, Finazzi M, Celebrano M, Neshev DN, Leo G.

Nano Lett. 2018 Nov 14;18(11):6750-6755. doi: 10.1021/acs.nanolett.8b02432. Epub 2018 Oct 18.

PMID:
30277790
33.

A computer-aided diagnosis system for the assessment and characterization of low-to-high suspicion thyroid nodules on ultrasound.

Gitto S, Grassi G, De Angelis C, Monaco CG, Sdao S, Sardanelli F, Sconfienza LM, Mauri G.

Radiol Med. 2019 Feb;124(2):118-125. doi: 10.1007/s11547-018-0942-z. Epub 2018 Sep 22.

PMID:
30244368
34.

Metal-dielectric hybrid nanoantennas for efficient frequency conversion at the anapole mode.

Gili VF, Ghirardini L, Rocco D, Marino G, Favero I, Roland I, Pellegrini G, Duò L, Finazzi M, Carletti L, Locatelli A, Lemaître A, Neshev D, De Angelis C, Leo G, Celebrano M.

Beilstein J Nanotechnol. 2018 Aug 27;9:2306-2314. doi: 10.3762/bjnano.9.215. eCollection 2018.

35.

Enhanced second-harmonic generation from two-dimensional MoSe2 on a silicon waveguide.

Chen H, Corboliou V, Solntsev AS, Choi DY, Vincenti MA, de Ceglia D, de Angelis C, Lu Y, Neshev DN.

Light Sci Appl. 2017 Oct 20;6(10):e17060. doi: 10.1038/lsa.2017.60. eCollection 2017 Oct.

36.

Is there a link between periampullary diverticula and biliopancreatic disease? An EUS approach to answer the question.

Bruno M, Ribaldone DG, Fasulo R, Gaia S, Marietti M, Risso A, Stradella D, Strona S, Saracco GM, De Angelis C.

Dig Liver Dis. 2018 Sep;50(9):925-930. doi: 10.1016/j.dld.2018.07.034. Epub 2018 Aug 4.

PMID:
30145052
37.

Synergistic antiproliferative and differentiating effect of 2,4-monofurfurylidene-tetra-O-methylsorbitol and 4,6-dimethyl-2-(3,4,5-trimethoxyphenylamino)pyrimidine on primary and immortalized keratinocytes.

Serafino A, Nicotera G, Andreola F, Giovannini D, Zonfrillo M, Sferrazza G, Calcaterra A, De Angelis C, Camponeschi C, Pierimarchi P.

Biomed Pharmacother. 2018 Nov;107:155-167. doi: 10.1016/j.biopha.2018.07.174. Epub 2018 Aug 4.

PMID:
30086462
38.

Giant Nonlinear Response at the Nanoscale Driven by Bound States in the Continuum.

Carletti L, Koshelev K, De Angelis C, Kivshar Y.

Phys Rev Lett. 2018 Jul 20;121(3):033903. doi: 10.1103/PhysRevLett.121.033903.

PMID:
30085788
39.

Neuropsychiatric Aspects in Men with Klinefelter Syndrome.

Giagulli VA, Campone B, Castellana M, Salzano C, Fisher AD, de Angelis C, Pivonello R, Colao A, Pasquali D, Maggi M, Triggiani V, On Behalf Of The Klinefelter ItaliaN Group King.

Endocr Metab Immune Disord Drug Targets. 2019;19(2):109-115. doi: 10.2174/1871530318666180703160250. Review.

PMID:
29972105
40.

Photo-induced heat generation in non-plasmonic nanoantennas.

Danesi S, Gandolfi M, Carletti L, Bontempi N, De Angelis C, Banfi F, Alessandri I.

Phys Chem Chem Phys. 2018 Jun 6;20(22):15307-15315. doi: 10.1039/c8cp01919c.

PMID:
29796465
41.

A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal adenocarcinoma.

Dennis K, Zeng L, De Angelis C, Chung H, Coburn N, Chow E, Wong CS.

Clin Transl Radiat Oncol. 2018 Apr 5;10:42-46. doi: 10.1016/j.ctro.2018.04.001. eCollection 2018 Mar.

42.

Real time quantitative analysis of lipid storage and lipolysis pathways by confocal spectral imaging of intracellular micropolarity.

Maulucci G, Di Giacinto F, De Angelis C, Cohen O, Daniel B, Ferreri C, De Spirito M, Sasson S.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jul;1863(7):783-793. doi: 10.1016/j.bbalip.2018.04.004. Epub 2018 Apr 11.

PMID:
29654826
43.

GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer.

Bhat RR, Yadav P, Sahay D, Bhargava DK, Creighton CJ, Yazdanfard S, Al-Rawi A, Yadav V, Qin L, Nanda S, Sethunath V, Fu X, De Angelis C, Narkar VA, Osborne CK, Schiff R, Trivedi MV.

Breast Cancer Res Treat. 2018 Jul;170(2):279-292. doi: 10.1007/s10549-018-4751-9. Epub 2018 Mar 24.

44.

A rare case of gastric fistulization of a main-duct intraductal papillary mucinous neoplasm.

Cortegoso Valdivia P, Bruno M, Gaia S, Saracco GM, De Angelis C.

Minerva Gastroenterol Dietol. 2018 Dec;64(4):383-385. doi: 10.23736/S1121-421X.18.02486-8. Epub 2018 Mar 16.

PMID:
29553226
45.

Aerobic exercise inhibits acute lung injury: from mouse to human evidence Exercise reduced lung injury markers in mouse and in cells.

Rigonato-Oliveira NC, Mackenzie B, Bachi ALL, Oliveira-Junior MC, Santos-Dias A, Brandao-Rangel MAR, Delle H, Costa-Guimaraes T, Damaceno-Rodrigues NR, Dulley NR, Benetti MA, Malfitano C, de Angelis C, Albertini R, Oliveira APL, Abbasi A, Northoff H, Vieira RP.

Exerc Immunol Rev. 2018;24:36-44.

46.

Successful endoscopic closure of tracheoesophageal fistula using a Padlock ClipTM.

Solidoro P, Venezia L, Patrucco F, De Angelis C.

Minerva Gastroenterol Dietol. 2018 Dec;64(4):388-390. doi: 10.23736/S1121-421X.18.02477-7. Epub 2018 Feb 14. No abstract available.

PMID:
29442487
47.

CHARACTERIZATION OF 27 MEV PROTON BEAM GENERATED BY TOP-IMPLART LINEAR ACCELERATOR.

De Angelis C, Ampollini A, Basile E, Cisbani E, Della Monaca S, Ghio F, Montereali RM, Picardi L, Piccinini M, Placido C, Ronsivalle C, Soriani A, Strigari L, Trinca E, Vadrucci M.

Radiat Prot Dosimetry. 2018 Aug 1;180(1-4):329-333. doi: 10.1093/rpd/ncy001.

PMID:
29385620
48.

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study.

Buono G, Crispo A, Giuliano M, De Angelis C, Schettini F, Forestieri V, Lauria R, Pensabene M, De Laurentiis M, Augustin LSA, Amore A, D'Aiuto M, Tortoriello R, Accurso A, Cavalcanti E, Botti G, Montella M, De Placido S, Arpino G.

Oncotarget. 2017 Dec 5;8(70):115709-115717. doi: 10.18632/oncotarget.22977. eCollection 2017 Dec 29.

49.

Urgent need to apply a common language in image-guided thermal ablations.

Mauri G, Pisani Mainini A, Monaco C, Pescatori LC, De Angelis C, Sconfienza LM.

J Ultrasound. 2018 Mar;21(1):77-78. doi: 10.1007/s40477-017-0278-x. Epub 2018 Jan 8. No abstract available.

50.

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.

De Angelis C, Di Maio M, Crispo A, Giuliano M, Schettini F, Bonotto M, Gerratana L, Iacono D, Cinausero M, Riccardi F, Ciancia G, De Laurentiis M, Puglisi F, De Placido S, Arpino G.

Oncotarget. 2017 Nov 24;8(68):112816-112824. doi: 10.18632/oncotarget.22643. eCollection 2017 Dec 22.

Supplemental Content

Loading ...
Support Center